Rankings
▼
Calendar
IMA FY 2023 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$67M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
-41.3% YoY
Gross Profit
$8M
88.9% margin
Operating Income
-$75M
-823.3% margin
Net Income
-$68M
-744.2% margin
EPS (Diluted)
$-1.63
Cash Flow
Operating Cash Flow
-$80M
Free Cash Flow
-$80M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$192M
Total Liabilities
$22M
Stockholders' Equity
$170M
Cash & Equivalents
$120M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$16M
-41.3%
Gross Profit
$8M
-$49M
+116.7%
Operating Income
-$75M
-$71M
-6.4%
Net Income
-$68M
-$69M
+0.9%
← Q4 2022
All Quarters
Q1 2023 →